CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

About CatalystAlert

Every biotech catalyst, confidence-rated and sourced — with AI entry-timing and a public, scored track record.

1,600+ Companies38,000+ CatalystsPublic Track Record

Our Mission

CatalystAlert is a biotech catalyst intelligence platform tracking FDA decisions, PDUFA dates, and clinical-trial readouts for 1,600+ biotech stocks. Every catalyst date carries a confidence rating — confirmed against an official regulatory source, estimated, or AI-detected — alongside AI entry-timing and a public, scored prediction track record.

CatalystAlert was built to democratize access to biotech catalyst intelligence — combining official regulatory data with machine learning to help investors track market-moving events.

Biotech is complex: FDA decisions, clinical-trial readouts, and PDUFA dates can move a stock sharply in a single day. We track these catalysts, label how reliable each date is, and publish our prediction track record openly — so you can judge the signal for yourself.

AI-Powered Intelligence

Our machine learning models analyze historical catalyst data to predict stock price movements.

Impact Prediction

Predicts the likely direction (up / neutral / down) of the stock around a catalyst event.

Scored live — see track record
LOA Scores

Likelihood of Approval scores based on drug phase, therapeutic area, and trial design.

Evidence-based
Entry Timing

A run-up conviction score for the pre-catalyst window — the move before the event, not the event itself.

Graded on the run-up

Data Sources

We aggregate data from official government sources and financial APIs to provide comprehensive coverage.

FDA OpenData

PDUFA dates, drug approvals, regulatory decisions

ClinicalTrials.gov

Clinical trial phases, enrollment, study design

SEC EDGAR

8-K filings, insider trades, 13F institutional holdings

Yahoo Finance

Stock prices, analyst ratings, market data

EMA & Health Canada

International regulatory decisions

PubMed & ChEMBL

Scientific publications, drug mechanisms

Plans & Pricing

CatalystAlert offers tiered plans to fit your needs. Start free, upgrade when you need more.

Free

$0

7-day catalyst calendar view, company search, watchlist, weekly digest
Pro

$29.99/mo

Full calendar, AI predictions (impact, LOA, entry timing), alerts, smart-money & insider data
Elite

$99.99/mo

Everything in Pro, plus API access and priority support
Important Disclaimer

CatalystAlert is for informational purposes only. Nothing on this website constitutes financial advice, investment advice, trading advice, or any other sort of advice.

You should not treat any of the content on this website as such. We do not recommend that any securities should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.

While we strive to provide accurate and timely information, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability of the information.

Past performance is not indicative of future results. Investing in biotech stocks carries significant risk, including the potential loss of principal.

What We Offer

Catalyst Calendar

Interactive calendar with all upcoming FDA dates, trial readouts, and company events

Company Profiles

Drug pipelines, catalyst timelines, analyst ratings, and smart money indicators

AI Predictions

ML-powered stock-impact predictions, LOA scores, and entry-timing signals

Push Notifications

Real-time alerts for FDA decisions, catalyst results, and watchlist updates

Connect With Us

Have questions, feedback, or want to stay updated? Reach out or follow us.

Follow us on X (Twitter) for daily catalyst alerts and market updates.

Ready to Get Started?

Explore our catalyst calendar for free, or sign up to unlock AI predictions and notifications.